Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis
- Conditions
- Aortic Valve Stenosis
- Interventions
- Device: Replacement of the Aortic Stenotic Valve
- Registration Number
- NCT01475799
- Lead Sponsor
- Direct Flow Medical, Inc.
- Brief Summary
The purpose of the study is to determine the safety and performance of the Direct Flow Medical study valve and delivery procedure.
- Detailed Description
Prospective, multicenter, non-randomized clinical trial of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the treatment of severe aortic stenosis
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 112
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Percutaneous Aortic Valve 18F System Replacement of the Aortic Stenotic Valve Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients with Severe Aortic Stenosis.
- Primary Outcome Measures
Name Time Method Freedom from all-cause mortality from procedure to 30 days Procedure to 30 days
- Secondary Outcome Measures
Name Time Method Device Success at procedure completion At procedure completion Device success is assessed at the completion of the study procedure based on TEE
Trial Locations
- Locations (12)
St. Bartholomew's Hospital
๐ฌ๐งLondon, United Kingdom
Clinique Pasteur
๐ซ๐ทToulouse, France
San Raffaele Hospital
๐ฎ๐นMilan, Italy
University Hospital Bonn
๐ฉ๐ชBonn, Germany
Vivantes Klinikum im Friedrichshain
๐ฉ๐ชBerlin, DE, Germany
Centre hospitalier de Luxembourg
๐ฑ๐บLuxembourg, Luxembourg
L'Institut Hospitalier Jacques Cartier
๐ซ๐ทMassy, France
Azienda Ospedaliera Niguarda Ca Granda
๐ฎ๐นMilan, Italy
Medical Care Center, Prof Mathey, Prof Schofer
๐ฉ๐ชHamburg, Germany
Elisabeth-Krankenhaus Essen, GmbH
๐ฉ๐ชEssen, Germany
Krankenhaus der Barmherzigen Brรผder Trier
๐ฉ๐ชTrier, Germany
St. Thomas' Hospital
๐ฌ๐งLondon, United Kingdom